The latest news from academia, regulators
research labs and other things of interest
Posted: September 9, 2008
MagForce Nanotechnologies to Present at the UBS Global Life Sciences Conference in New York
(Nanowerk News) MagForce Nanotechnologies AG will be presenting at this year’s UBS Global Life Sciences Conference in New York City. Dr. Uwe Maschek, CEO of MagForce Nanotechnologies, will provide an investor overview of the company and discuss the current status of its Nano-Cancer® therapy. The presentation will take place at the Grand Hyatt New York on September 25, 2008, starting at 11:00 a.m.
The annual UBS Global Life Sciences Conference is one of the world’s largest investor events within the pharmaceutical, medical technology and biotechnology sector, with more than 350 companies introducing their latest products and most promising research and development efforts to institutional investors.
Two days prior to this conference, on September 23 starting at 11:30 a.m., Dr. Maschek will deliver a company presentation at AdvaMed 2008 in Washington, D.C. AdvaMed is the annual conference of the Advanced Medical Technology Association, the U.S. industry association for medical technology.
About MagForce Nanotechnologies:
About MagForce Nanotechnologies
MagForce Nanotechnologies AG is the worlds leading company in the area of nanotechnology-based cancer therapy. Its patented therapy allows the targeted destruction of tumors using magnetic nanoparticles. MagForces nanotechnology represents a revolutionary approach to the future successful treatment of solid tumors.